As the biopharmaceutical equipment vaccine market continues to expand, biopharmaceutical equipment will help accelerate its development. According to data, a total of 651 million vaccines will be issued in 2020, an increase of 14.39% year-on-year. Among them, 348 million was issued for the first type of vaccine, a year-on-year increase of 0.62%, the second type of vaccine was issued 303 million, a year-on-year increase of 35.76%, and the domestic vaccine was 600 million, a year-on-year increase of 13.68%. Industry insiders believe that the above data not only fully interprets the main theme of the vaccine industry "variety is king", but also shows that the vaccine market is expanding.

In fact, vaccines are vaccine-like preventive biological products used to prevent and control the occurrence and prevalence of infectious diseases. In recent years, with the development of the domestic vaccine industry and the continuous expansion of the scope of research and development and production of various veterinary and human vaccines, the entire vaccine industry is also developing rapidly. It is worth noting that, in this context, domestically produced blockbuster products have successively opened the way to the market, and have gradually become a new support point for the continuous rapid growth of the industry market.
However, with the continuous expansion of the vaccine market, the industry generally believes that in the future, the vaccine industry will be in an environment of high attention given by all walks of life and strict national supervision. After all, the safety requirements of vaccines have always been higher than those of general medicines. In this context, for the vaccine industry, stronger safety guarantees, more complete self-examination and self-regulation systems, and more cutting-edge technology and pharmaceutical equipment support will all be the focus of the industry's future development.

The industry believes that the key to the development of the vaccine market lies in product quality. Only under the premise of guaranteed quality can we have long-term development space. Therefore, the vaccine industry also needs more professional purification equipment and systems to provide high-quality hardware and software support. It is understood that in the field of pharmaceutical equipment, pharmaceutical data is the "identity card" of vaccines, which has always played a vital role in quality control. According to the author's understanding, many pharmaceutical equipment companies have already begun to carry out equipment transformation and innovation for vaccine research and development, production, and storage to help the further development of the vaccine industry.

For example, in the research and development process, because the research and development of vaccines and biological drugs are under great pressure, how to speed up the efficiency in the complicated and long research and development process, reduce costs and ensure the safety and stability of products is very important. Pharmaceutical equipment companies provide a complete set of bioprocess solutions for domestic and foreign biopharmaceutical companies. From the hardware point of view, this process includes disposable bioreactors, equipment, and consumables for the production and development of vaccine products to provide high-precision technology. From the perspective of software, there is also a dedicated process analysis and control platform, with data and algorithms as the basis.

In addition, in the production process, some companies are adhering to years of experience in purification engineering and are vigorously expanding the field of biomedicine, especially the technology and engineering services of high-level biosafety protection workshops. At the same time, optimization measures have also been proposed for the construction of the third-level biosafety protection workshop. It deliberately organized an elite technical solution team to conduct GMP compliance and construction feasibility assessments on the original three-level biosafety protection workshop, and proposed missing and wrong items in the design schemes such as process, HVAC, and automatic control. Provided many professional opinions on deepening optimization and completed the second optimization.

In general, with the great attention of the country and the industry, the vaccine industry is accelerating its path toward large-scale and intensification. Correspondingly, the industry's requirements for quality and safety are becoming more and more stringent. Therefore, with the rapid development of the vaccine industry, the vaccine industry must resolutely maintain the bottom line of quality and safety, continuously improve and upgrade the technology of pharmaceutical equipment, and adhere to the road of high-quality development.

相關文章

相關產品